发明名称 |
DRY POWDER INHALER |
摘要 |
This invention provides a dry powder inhaler comprising: a dry powder medicament comprising fluticasone propionate, salmeterol xinafoate and a lactose carrier; wherein, the delivered dose of salmeterol per actuation is less than 50 µg; and wherein the dose provides a baseline-adjusted FEV1 in a patient of more than 150 mL within 30 minutes of receiving the dose. A method of treating a patient includes administering to a patient a dry powder medicament having fluticasone propionate, salmeterol xinafoate and a lactose carrier; wherein, the delivered dose of salmeterol per actuation is less than 50 µg; and wherein the dose provides a baseline-adjusted FEV1in a patient of more than 150 mL within 30 minutes of receiving the dose. |
申请公布号 |
CA2926432(A1) |
申请公布日期 |
2015.04.16 |
申请号 |
CA20142926432 |
申请日期 |
2014.10.06 |
申请人 |
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. |
发明人 |
DALVI, MUKUL;TEE, SEAH KEE |
分类号 |
A61K9/12;A61K31/137;A61K31/56;A61M15/00 |
主分类号 |
A61K9/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|